Short Interest in AirSculpt Technologies, Inc. (NASDAQ:AIRS) Drops By 28.9%

AirSculpt Technologies, Inc. (NASDAQ:AIRS) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 3,416,693 shares, a drop of 28.9% from the November 30th total of 4,804,380 shares. Currently, 23.4% of the shares of the company are sold short. Based on an average daily trading volume, of 683,627 shares, the short-interest ratio is currently 5.0 days. Based on an average daily trading volume, of 683,627 shares, the short-interest ratio is currently 5.0 days. Currently, 23.4% of the shares of the company are sold short.

Institutional Investors Weigh In On AirSculpt Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vesey Street Capital Partners L.L.C. lifted its holdings in AirSculpt Technologies by 3.4% during the second quarter. Vesey Street Capital Partners L.L.C. now owns 30,324,180 shares of the company’s stock valued at $146,466,000 after purchasing an additional 1,000,000 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of AirSculpt Technologies during the second quarter worth about $50,000. Matauro LLC acquired a new position in shares of AirSculpt Technologies during the 2nd quarter worth about $557,000. Kapitalo Investimentos Ltda acquired a new position in shares of AirSculpt Technologies during the 2nd quarter worth about $51,000. Finally, Citizens Financial Group Inc. RI lifted its stake in AirSculpt Technologies by 49.1% in the 2nd quarter. Citizens Financial Group Inc. RI now owns 147,900 shares of the company’s stock valued at $714,000 after buying an additional 48,734 shares in the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on AIRS. Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a research note on Monday, December 22nd. Leerink Partners reissued a “market perform” rating and issued a $6.00 price target on shares of AirSculpt Technologies in a report on Tuesday, November 11th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, AirSculpt Technologies currently has a consensus rating of “Reduce” and a consensus price target of $5.50.

AirSculpt Technologies Price Performance

Shares of AirSculpt Technologies stock opened at $1.99 on Tuesday. The firm has a market cap of $124.26 million, a PE ratio of -6.63 and a beta of 2.63. AirSculpt Technologies has a twelve month low of $1.53 and a twelve month high of $12.00. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63. The business has a 50-day moving average price of $5.31 and a 200 day moving average price of $6.03.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Friday, November 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.03). The business had revenue of $34.99 million for the quarter, compared to analysts’ expectations of $39.80 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%. Sell-side analysts predict that AirSculpt Technologies will post -0.01 earnings per share for the current fiscal year.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.